Market cap
₹15.2 cr
Loading the extract…
Healthcare · Pharmaceuticals
526075 · BSE 526075
Market cap
₹15.2 cr
Price
25.2
52w high
46.6
52w low
6.75
PE
—
Industry PE
—
Book value
-1.02
Dividend yield
0%
ROCE
-333
ROE
—
Debt / equity
—
EPS
—
No description in this extract.
| Line | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Dividend Payout % | 0 | 0 | 0 | — | 0 |
| EPS in Rs | -0.21 | -0.12 | -0.02 | 0 | -0.07 |
| Expenses | 1.52 | 0.14 | 0.02 | 0 | 0.04 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0.25 | -0.14 | -0.02 |
| Line | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS in Rs | -0.05 | -0.1 | -0.02 | -0.03 | -0.03 | -0.02 | -0.06 | 0 |
| Expenses | 0.78 | 0.47 | 0.23 | 0.04 | 0.04 | 0.02 | 0.07 | 0 |
| Interest | 0 |
| Line | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 41.3 | 41.3 | 41.3 | 41.3 | 41.3 | 41.3 | 41.3 | 41.3 |
| Public | 58.7 | 58.72 | 58.72 | 58.72 | 58.71 | 58.7 | 58.7 | 58.7 |
| 0 |
| -0.08 |
| OPM % | -19.69 | — | — | — | — |
| Operating Profit | -0.25 | -0.14 | -0.02 | 0 | -0.08 |
| Other Income | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.25 | -0.14 | -0.02 | 0 | -0.08 |
| Sales | 1.27 | 0 | 0 | 0 | -0.04 |
| Tax % | 0 | 0 | 0 | — | 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| Net Profit | -0.06 | -0.12 | -0.03 | -0.04 | -0.04 | -0.02 | -0.07 | 0 |
| OPM % | -8.33 | -34.29 | -15 | — | — | — | — | — |
| Operating Profit | -0.06 | -0.12 | -0.03 | -0.04 | -0.04 | -0.02 | -0.07 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.06 | -0.12 | -0.03 | -0.04 | -0.04 | -0.02 | -0.07 | 0 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Sales | 0.72 | 0.35 | 0.2 | 0 | 0 | 0 | 0 | 0 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |